Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
08/2003
08/21/2003WO2003068963A1 Deoxyribozymes
08/21/2003WO2003068958A1 Method of analyzing nucleic acid specifying gene showing change in expression dose due to schizophrenia
08/21/2003WO2003068957A1 METHOD OF SCREENING INK4 FAMILY GENE EXPRESSION CONTROLLER AND p19 GENE PROMOTER
08/21/2003WO2003068956A1 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries
08/21/2003WO2003068947A1 Assay electrodes having immobilized lipid/protein layers and methods of making and using the same
08/21/2003WO2003068938A2 Human fetal bladder-derived epithelial cells
08/21/2003WO2003068932A2 Method for crystallizing human gsk3 and novel crystal structure thereof
08/21/2003WO2003068928A2 Gene function inferring using gene expression data
08/21/2003WO2003068927A2 Method for influencing kinase activity with ag879 and ag879 derivatives
08/21/2003WO2003068923A2 Signal for packaging of influenza virus vectors
08/21/2003WO2003068919A2 Non-invasive method for measuring rates of biosynthesis of biological molecules by label incorporation
08/21/2003WO2003068918A2 High-sensitivity real-time polymerase chain reaction for detection of nucleic acids
08/21/2003WO2003068916A2 Methods and apparatus for whole cell panning
08/21/2003WO2003068908A2 Cardiotoxin molecular toxicology modeling
08/21/2003WO2003068906A1 Systems and methods for rapidly changing the solution environment around sensors
08/21/2003WO2003068814A1 Novel genes functionally related to dyslexia
08/21/2003WO2003068813A2 Group b streptococcus antigen
08/21/2003WO2003068811A2 Cytotoxic t-cell epitopes from chlamydia
08/21/2003WO2003068803A2 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
08/21/2003WO2003068797A1 Methods for producing interfering rna molecules in mammalian cells and therapeutic uses for such molecules
08/21/2003WO2003068788A1 Method of isolating nucleic acids from stool samples
08/21/2003WO2003068712A2 Novel method for production of dna biochips and applications thereof
08/21/2003WO2003068201A2 High affinity antibody having a tcr-like specificity and use in detection and treatment
08/21/2003WO2003068151A2 Human antibodies for therapy against vaccinia or smallpox
08/21/2003WO2003068146A2 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
08/21/2003WO2003068054A2 Identification of ovarian cancer tumor markers and therapeutic targets
08/21/2003WO2003068050A2 Method for the detecion of carcinoembryonic agent and cancer diagnosis method based thereon
08/21/2003WO2003060142A9 Compositions and methods for controlled release
08/21/2003WO2003056296A8 Improved methods for determining binding affinities
08/21/2003WO2003055913A3 Secreted protein
08/21/2003WO2003048352A3 Histone h3 methyltransferase polypeptide
08/21/2003WO2003047037A3 Fabrication of a high resolution biological molecule detection device with aluminum electrical conductors
08/21/2003WO2003045227A3 Single nucleotide polymorphisms and combinations thereof predictive for paclitaxel responsiveness
08/21/2003WO2003044176A8 Functional polymorphisms of the interleukin-1 locus affecting transcription and susceptibility to inflammatory and infectious diseases
08/21/2003WO2003042245A3 Growth hormone variations in humans and their uses
08/21/2003WO2003037254A3 Methods and compositions for the treatment and diagnosis of pain disorders using 46566
08/21/2003WO2003031641A3 Beta 2 adrenergic polymorphism detection
08/21/2003WO2003029451A3 Histone deacetylase 9
08/21/2003WO2003028631A3 Drug targets for alzheimer's disease and other diseases associated with decreased neuronal metabolism
08/21/2003WO2003027245B1 CONVERSION OF RED BLOOD CELLS A, B, AND AB USING a-N-ACETYLGALACTOSAMINIDASES AND a-GALACTOSIDASE
08/21/2003WO2003021256A8 Method for identifying polymorphic markers in a population
08/21/2003WO2003021224A3 Methods for identifying heterozygous carriers of autosomal recessive diseases
08/21/2003WO2003020895A3 Method of determining the nucleotide sequence of oligonucleotides and dna molecules
08/21/2003WO2003020751A3 Homing peptides
08/21/2003WO2003018760A3 Screening assays for identifying differentiation-inducing agents and production of differentiated cells for cell therapy
08/21/2003WO2003016565A3 Dna sequence analysis
08/21/2003WO2003016504A3 Polymorphisms associated with ion-channel disease
08/21/2003WO2003014699A8 Compositions and methods for detecting and quantifying cox-2 activity by lipoamino acid metabolism
08/21/2003WO2003011131A3 Sensor head for monitoring glucose for use with implantable devices
08/21/2003WO2003008643A3 Methods and polynukleotides for assaying the activity of a dna modifying enzyme
08/21/2003WO2003008539A3 Non-alloying core shell nanoparticles
08/21/2003WO2003004686A3 Fluorescence-based assay for the detection of specific nucleic acids using photon counting
08/21/2003WO2002097127A3 Genes and proteins for prevention, prediction, diagnosis, prognosis and treatment of chronic lung disease
08/21/2003WO2002097123A3 Diagnostic methods for cardiovascular disease, low hdl-cholesterol levels, and high triglyceride levels
08/21/2003WO2002094995A3 Methods and compositions using genetic package display
08/21/2003WO2002089739A3 Peptide deformylase activated prodrugs
08/21/2003WO2002083838A3 Elimination of endogenous porcine retrovirus
08/21/2003WO2002082075A3 Method for detecting chronic dementia diseases, and corresponding peptides and detection reagents
08/21/2003WO2002079504A3 Neotic and endoapoptotic cells and detection of neosis and endoapoptosis
08/21/2003WO2002077271A3 Control plasmid and method for detecting mycoplasma contamination in biological material
08/21/2003WO2002074810A3 Isolated human ion channel proteins, nucleic acid molecules encoding human ion channel proteins, and uses thereof
08/21/2003WO2002072140A3 Mhc-i-restricted presentation of hiv-1 virion antigens without viral replication. application to the stimulation of ctl and vaccination in vivo; analysis of vaccinating composition in vitro
08/21/2003WO2002070727A3 Polynucleotide encoding a novel human potassium channel beta-subunit, k+betam6, expressed highly in the small intestine
08/21/2003WO2002070695A3 Tumor associated proteins
08/21/2003WO2002068473A8 Biosensor for detecting chemical agents
08/21/2003WO2002064748A3 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
08/21/2003WO2002064731B1 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
08/21/2003WO2002062999A3 Proteins and nucleic acids encoding same
08/21/2003WO2002059353A3 Two-step amplification using a program primer followed by specific primers
08/21/2003WO2002059273A3 Particle sizer and dna sequencer
08/21/2003WO2002058623A3 Inhibitors of spermidine synthase for the treatment of osteoarthritis and cartilage rehabilitation
08/21/2003WO2002057452A3 Human proteins, polynucleotides encoding them and methods of using the same
08/21/2003WO2002056022A3 Diagnostics, drug screening and treatment for cancer
08/21/2003WO2002051977A3 orfE-ZipA INTERACTION AND USES THEREOF
08/21/2003WO2002050545A3 Compositions and methods involving staphylococcus aureus protein staau-r9
08/21/2003WO2002050536A3 Replication assay for detecting anti-viral substances
08/21/2003WO2002048405A3 Non-invasive method for detecting target rna
08/21/2003WO2002048399A3 Method for the simultaneous dissection in specific positions of filiform organic molecular chains, in particular dna
08/21/2003WO2002046765A3 Compositions, kits, and methods for identification, assessment, prevention, and therapy of ovarian cancer
08/21/2003WO2002046462A3 Functional genetic variants of matrix metalloproteinases (nmps)
08/21/2003WO2002046449A3 Selection of catalytic nucleic acids targeted to infectious agents
08/21/2003WO2002046224A3 Compositions and methods relating to lung specific genes and proteins
08/21/2003WO2002044425A3 Enzymatic nucleic acid synthesis: compositions and methods for altering monomer incorporation fidelity
08/21/2003WO2002044418A3 Expression analysis of fkbp nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
08/21/2003WO2002044209A3 Cytonkine receptor zcytor19
08/21/2003WO2002040717A3 In vitro cell-based methods for biological validation and pharmacological screening of chemical entities and biologicals
08/21/2003WO2002040535A3 Compositions and methods relating to ovary specific genes and proteins
08/21/2003WO2002035240A3 Methods for identifying compounds for regulating muscle mass or function using vasoactive intestinal peptide receptors
08/21/2003WO2002033638A3 Mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance
08/21/2003WO2002033128A3 Multiplex quantification of nucleic acids in diseased cells
08/21/2003WO2002029113A3 Methods for monitoring multiple gene expression
08/21/2003WO2002029083A3 Industrial-scale serum-free production of recombinant proteins in mammalian cells
08/21/2003WO2002024959A3 Multiple reporter read-out for bioassays
08/21/2003WO2002022890A3 Compositions, methods and kits for determining the presence of cryptosporidium organisms in a test sample
08/21/2003WO2002022882A3 Target activated nucleic acid biosensor and methods of using same
08/21/2003WO2002022879A3 Detection of microsatellite instability and its use in diagnosis of tumors
08/21/2003WO2002020722A9 Methods and compositions for in vitro targeting
08/21/2003WO2002018655A3 Compositions and methods for the generation of single stranded cdna microarrays with accurate universal quantitation reference
08/21/2003WO2002012284A3 Iron regulating protein-2 (irp-2) as a diagnostic for neurodegenerative disease
08/21/2003WO2002010433A3 Method and device for detecting bacterial contamination